<table id="id_4a0786f4-a73b-455e-b219-db776c716b0f" width="559.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_bdee025f-c97a-4d09-893a-fa95f1e64f3e">Table 5: Results of Drug Interaction Studies with Buggered Formulations of Didanosine: Effects of Coadministered Drug on Didanosine plasma AUC and Cmax Values</caption>
<col width="22.5%"></col>
<col width="21.6%"></col>
<col width="10.7%"></col>
<col width="18.6%"></col>
<col width="26.5%"></col>
<tbody>
<tr id="id_e1c973e8-e0b2-44b8-adb4-011fa80a83a7">
<td align="left" colspan="5" stylecode="Botrule" valign="top">
<content stylecode="bold">
<content stylecode="italics">Drugs With Clinical Recommendations Regarding Coadministration (see <linkhtml href="#i4i_precautions_id_f4cc5e95-2654-4087-9204-9cccccdee8f4" title="PRECAUTIONS">PRECAUTIONS</linkhtml>, <linkhtml href="#i4i_section_id_4a23ef6f-0540-491d-9fe1-84627cbaa7de">Drug Interactions</linkhtml> )</content>
</content>
</td>
</tr>
<tr id="id_dc5549d6-2b99-42f3-b4a0-1394cc41c1eb">
<td align="left" stylecode="Botrule Rrule" valign="top">Drug</td>
<td align="left" stylecode="Botrule Rrule" valign="top">Didanosine Dosage</td>
<td align="left" stylecode="Botrule Rrule" valign="top">n</td>
<td align="left" stylecode="Botrule Rrule" valign="top">AUC Didanosine (95% CI)</td>
<td align="left" stylecode="Botrule" valign="top">Cmax of Didanosine (95% CI)</td>
</tr>
<tr id="id_77e12777-3623-49a5-a648-62d13b32f3b6">
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>
<content stylecode="bold">allopurinol</content>,</paragraph>
<paragraph>Renally impaired, 300 mg/day</paragraph>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">200 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">2</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑312%</td>
<td align="left" stylecode="Botrule" valign="top">↑232%</td>
</tr>
<tr id="id_27803c18-6935-4f2c-a1fa-e2e1cd56f4ae">
<td align="left" stylecode="Botrule Rrule" valign="top">healthy volunteer, 300 mg/day for 7 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">400 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">14</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑113%</td>
<td align="left" stylecode="Botrule" valign="top">↑69%</td>
</tr>
<tr id="id_b3c111f1-b101-4a7a-9ef7-d816bda144f7">
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">ganciclovir</content>, 1000 mg q8h, 2 h after didanosine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">200 mg q12h</td>
<td align="left" stylecode="Botrule Rrule" valign="top">12</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑111%</td>
<td align="left" stylecode="Botrule" valign="top">NA</td>
</tr>
<tr id="id_0fbac54c-de47-436f-a663-36974711fa3b">
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">methadone</content>, chronic maintenance dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">200 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">16, 10<sup>a</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↓57%</td>
<td align="left" stylecode="Botrule" valign="top">↓66%</td>
</tr>
<tr id="id_94f69315-5df2-42f9-8f47-14153b39164e">
<td align="left" stylecode="Botrule Rrule" valign="top">
<content stylecode="bold">tenofovir</content>,<sup>b</sup> 300 mg once daily 1 h after didanosine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">250<sup>c</sup> or 400 mg once daily for 7 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">14</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑44% (31, 59%)<sup>d</sup>
</td>
<td align="left" stylecode="Botrule" valign="top">↔28% (11, 48%)<sup>d</sup>
</td>
</tr>
<tr id="id_33446980-38f1-4e1f-b58c-bb05ffc5e0dc">
<td align="left" colspan="5" stylecode="Botrule" valign="top">
<content stylecode="bold">No Clinically Significant Interactions Observed</content>
</td>
</tr>
<tr id="id_3d9d13dd-7739-4c1d-9306-44e21de8f0a9">
<td align="left" stylecode="Botrule Rrule" valign="top">ciprofloxacin, 750 mg q12h for 3 days, 2 h before didanosine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">200 mg q12h for 3 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">8<sup>e</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↓16%</td>
<td align="left" stylecode="Botrule" valign="top">↓28%</td>
</tr>
<tr id="id_02b5fd1c-a470-48b8-bd32-4afc99d64cc4">
<td align="left" stylecode="Botrule Rrule" valign="top">ininavir, 800 mg single dose simultaneous</td>
<td align="left" stylecode="Botrule Rrule" valign="top">200 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">16</td>
<td align="left" stylecode="Botrule Rrule" valign="top">
<paragraph>↔</paragraph>
</td>
<td align="left" stylecode="Botrule" valign="top">
<paragraph>↔</paragraph>
</td>
</tr>
<tr id="id_5a3fc7a7-24d7-41aa-abae-70a136027cfc">
<td align="left" stylecode="Botrule Rrule" valign="top">1 h before didanosine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">200 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">16</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↓17% (-27, -7%)<sup>d</sup>
</td>
<td align="left" stylecode="Botrule" valign="top">↓13% (-28, 5%)<sup>d</sup>
</td>
</tr>
<tr id="id_2b1cad9d-0273-4839-9338-7c4697c0fff3">
<td align="left" stylecode="Botrule Rrule" valign="top">ketoconazole, 200 mg/day for 4 days, 2 h before didanosine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">375 mg q12h for 4 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">12<sup>e</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↔</td>
<td align="left" stylecode="Botrule" valign="top">↓12%</td>
</tr>
<tr id="id_cc73bc0a-a940-4afc-b2e2-fd89170413a6">
<td align="left" stylecode="Botrule Rrule" valign="top">loperamide, 4 mg q6h for 1 day</td>
<td align="left" stylecode="Botrule Rrule" valign="top">300 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">12<sup>e</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↔</td>
<td align="left" stylecode="Botrule" valign="top">↓23%</td>
</tr>
<tr id="id_11052a1a-4f5d-40a7-a0b2-b91f3638e33d">
<td align="left" stylecode="Botrule Rrule" valign="top">metoclopramide, 10 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">300 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">12<sup>e</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↔</td>
<td align="left" stylecode="Botrule" valign="top">↑13%</td>
</tr>
<tr id="id_42df9ef7-054a-4528-bb37-9d744d8482e9">
<td align="left" stylecode="Botrule Rrule" valign="top">ranitidine, 150 mg 2 h before didansine</td>
<td align="left" stylecode="Botrule Rrule" valign="top">375 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">12<sup>e</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑14%</td>
<td align="left" stylecode="Botrule" valign="top">↑13%</td>
</tr>
<tr id="id_1245bfa3-ee3f-42af-ab83-07cac0fa8b78">
<td align="left" stylecode="Botrule Rrule" valign="top">rifabutin, 300 or 600 mg/day for 12 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">167 or 250 mg q12h for 12 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">11</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↑13% (-1, 27%)</td>
<td align="left" stylecode="Botrule" valign="top">↑17% (-4, 38%)</td>
</tr>
<tr id="id_9e56a762-8b1a-4cd9-97d7-0677cdf13e9d">
<td align="left" stylecode="Botrule Rrule" valign="top">ritonavir, 600 mg q12h for 4 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">200 mg q12h for 4 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">12</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↓13% (0, 23%)</td>
<td align="left" stylecode="Botrule" valign="top">↓16% (5, 26%)</td>
</tr>
<tr id="id_4cb6ca3e-93f5-410f-97bb-95a3b346cb7b">
<td align="left" stylecode="Botrule Rrule" valign="top">stavudine, 40 mg q12h for 4 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">100 mg q12h for 4 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">10</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↔</td>
<td align="left" stylecode="Botrule" valign="top">↔</td>
</tr>
<tr id="id_8ac099e3-c3e5-4998-bd88-65df379c659e">
<td align="left" stylecode="Botrule Rrule" valign="top">sulfamethoxazole, 1000 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">200 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">8<sup>e</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↔</td>
<td align="left" stylecode="Botrule" valign="top">↔</td>
</tr>
<tr id="id_4cf37836-89e7-405d-b585-eaa3fc0d8576">
<td align="left" stylecode="Botrule Rrule" valign="top">trimethoprim, 200 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">200 mg single dose</td>
<td align="left" stylecode="Botrule Rrule" valign="top">8<sup>e</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↔</td>
<td align="left" stylecode="Botrule" valign="top">↑17% (-23, 77%)</td>
</tr>
<tr id="id_17d4b96b-7bcb-4759-98be-08a8449bdafa">
<td align="left" stylecode="Botrule Rrule" valign="top">zidovudine, 200 mg q7h for 3 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top"> 200 mg q12h for 3 days</td>
<td align="left" stylecode="Botrule Rrule" valign="top">8<sup>e</sup>
</td>
<td align="left" stylecode="Botrule Rrule" valign="top">↔</td>
<td align="left" stylecode="Botrule" valign="top">↔</td>
</tr>
<tr id="id_6be1ff8c-e739-4a81-9874-78f6a7e83f7a">
<td align="left" colspan="5" stylecode="Lrule Botrule" valign="top">
<paragraph>↑ indicates increase<br/>↓ indicates decrease<br/>↔ indicates no change, or mean increase or decrease of &lt;10%.<br/>
<sup>a</sup> Parellel-group design; entries are subjects receiving combination and control regimens, respectively.<br/>
<sup>b</sup> tenogovir disoproxil fumarate<br/>
<sup>c</sup> patients &lt;60 kg with creatinine clearance &gt;60 mL/min.</paragraph>
<paragraph>
<sup>d</sup> 90% CI<br/>
<sup>e</sup> HIV-infected patients<br/>N/A Not available</paragraph>
</td>
</tr>
</tbody>
</table>